Characterising Arm Recovery in People With Severe Stroke (CARPSS)

January 9, 2017 updated by: University of British Columbia
The main goal of this program of research is to advance our understanding of how the severely damaged brain changes over the first 12-months post stroke. The investigators will determine 'who recovers', 'who does not recover', and 'why'

Study Overview

Status

Unknown

Conditions

Detailed Description

The main goal of this program of research is to advance our understanding of how the severely damaged brain changes over the first 12-months post stroke. The prevalence and severity of stroke related arm disability is increasing and the prospect of optimal recovery is poor. Studies have demonstrated that stroke survivors with severe disability lack early indicators (<7-days to <1-month post-stroke) of a good prognosis, such as active movement at the shoulder and wrist and integrity of the corticospinal tract. This has propagated the clinical belief that this cohort are unlikely to functionally benefit from rehabilitation efforts. However, it is possible that indicators of potential for recovery - either neuroanatomical or clinical - may present in individuals with severe stroke later, that is beyond the early time-period. Indeed, there is increasing evidence of the potential for ongoing improvements in motor performance in response to intensive interventions that are undertaken 6-months or more post-stroke. This therefore, implies that there is some degree of untapped recovery potential. However, as very few studies have longitudinally explored the potential indicators of recovery in a severe cohort, the dynamic capacity of the severely damaged remains unknown. Thus, there is a need to determine 'who recovers', 'who does not recover', and 'why' to be able to promote optimal arm recovery in people with severe impairment after stroke. We will assess stroke survivors <4-weeks, 3-months, 6-months and 12-months post stroke using a range of neuroimaging and clinical outcome measures. The findings from this study will build the foundations for more personalized health care options for people with severe arm impairment post stroke.

Study Type

Observational

Enrollment (Anticipated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • British Columbia
      • Vancouver, British Columbia, Canada, V6T1Z3
        • Recruiting
        • University of British Columbia
        • Contact:
        • Contact:
        • Sub-Investigator:
          • Julie Bernhardt, PT PhD
        • Principal Investigator:
          • Lara A Boyd, PT PhD
        • Sub-Investigator:
          • Kathryn S Hayward, PT PhD
        • Sub-Investigator:
          • Catherine E Lang, PT PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Stroke survivors with subacute and severe upper limb disability will be evaluated longitudinally.

Description

Inclusion Criteria:

  • adults aged 18 to 90 years;
  • sustained their first stroke;
  • demonstrate subacute (<1 month) and severe upper limb motor deficits (defined by a SAFE [shoulder abduction and finger extension] score of <5 out of 10 points); and
  • can follow single stage commands

Exclusion Criteria:

  • neurological condition other than stroke e.g., Parkinson's disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Longitudinal evaluation of recovery
Stroke survivors with subacute and severe upper limb disability
Stroke survivors will be assessed at four time frames post stroke to evaluate neuroplastic and clinical changes in arm recovery over the first 12-months post stroke.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
3T Magnetic Resonance Imaging (MRI)
Time Frame: up to 12-months
Determine the structural and functional connectivity of the brain using diffusion weighted imaging, resting state-functional magnetic resonance imaging and myelin water fraction imaging.
up to 12-months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Shoulder abduction and finger extension (SAFE)
Time Frame: 12-months
Measurement of upper limb strength
12-months
Fugl-Meyer Assessment (arm and sensory)
Time Frame: <4wks, 3-months, 6-months, 12-months
Measurement of upper limb impairment
<4wks, 3-months, 6-months, 12-months
Motor Assessment Scale items 6,7,8
Time Frame: <4wks, 3-months, 6-months, 12-months
Measurement of upper limb activity
<4wks, 3-months, 6-months, 12-months
REACH (Rating of Everyday Arm Use in the Community and Home)
Time Frame: <4wks, 3-months, 6-months, 12-months
Self-report measure of everyday arm use
<4wks, 3-months, 6-months, 12-months
Accelerometry
Time Frame: <4wks, 3-months, 6-months, 12-months
Measurement of real world arm use (activity count) over a 7-day period at each time frame
<4wks, 3-months, 6-months, 12-months
PASS (Postural Assessment Scale for Stroke patients)
Time Frame: <4wks, 3-months, 6-months, 12-months
Measurement of balance (static and dynamic) and lower limb functional tasks
<4wks, 3-months, 6-months, 12-months
10-metre walk test
Time Frame: <4wks, 3-months, 6-months, 12-months
Measurement of walking ability
<4wks, 3-months, 6-months, 12-months
Montreal Cognitive Assessment (MoCA)
Time Frame: <4wks, 3-months, 6-months, 12-months
Measurement of cognitive impairment after stroke
<4wks, 3-months, 6-months, 12-months
Dose of upper limb training
Time Frame: <4wks, 3-months, 6-months, 12-months
Dose in minutes of passive, active, functional or sensory upper limb tasks performed over a 7-day period at each time frame
<4wks, 3-months, 6-months, 12-months
National Institute of Stroke Severity Scale
Time Frame: <4-weeks
Characterise stroke severity
<4-weeks
Oxfordshire Bamford Classification
Time Frame: <4-weeks
Characterise stroke type
<4-weeks
Myelin water fraction imaging (WMI)
Time Frame: <4wks, 3-months, 6-months, 12-months
Determine the myelin content within the brain
<4wks, 3-months, 6-months, 12-months
Meaningful arm recovery questionnaire
Time Frame: <4wks, 3-months, 6-months, 12-months
Explore the stroke survivor's perception of meaningful recovery of their upper limb
<4wks, 3-months, 6-months, 12-months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lara A Boyd, PT PhD, University of British Columbia

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2015

Primary Completion (Anticipated)

December 1, 2018

Study Completion (Anticipated)

December 1, 2019

Study Registration Dates

First Submitted

June 3, 2015

First Submitted That Met QC Criteria

June 4, 2015

First Posted (Estimate)

June 8, 2015

Study Record Updates

Last Update Posted (Estimate)

January 10, 2017

Last Update Submitted That Met QC Criteria

January 9, 2017

Last Verified

January 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Longitudinal evaluation of recovery

3
Subscribe